RE:RE:RE:RE:When comparing with SONA... DM has an Antigen test as well which is awaiting HC approval... just like Sona. Investors over on the Sona board talk as if they are the only player in this game sometimes. Granted, I'd give Sona the edge since HC has made it perfectly clear they prefer working with actual healthcare companies. Does that justify the MC discrepancy between DM and Sona? Not even a little bit IMO.
Jjpiz1 wrote: Sonas value lies in that it has an antigen test not a shitty antibody test. It's tech is revolutionary for c-19.